Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment

Completed · Not applicable · Has a placebo group

Conditions studied: Healthy

In brief

The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.

Key facts

Study ID

NCT03369925

Run by

Kyowa Hakko Bio Co., Ltd.

People needed

100

Starts

2018-01-02

Expected to finish

2018-12-03

Last updated by the study team

2019-02-27

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• male or female, 50-85 years of age
• at least a high school diploma or the equivalent
• self-reported memory loss
• scores ≥24 on the Mini-Mental State Examination, ≥85 on the Kaufman Brief Intelligence Test, Second Edition, ≤5 on the Geriatric Depression Scale, and 4, 3, or 2 on the Spatial Span Test
• no health conditions that would prevent him or her from fulfilling the study requirements on the basis of medical history and routine laboratory test results

You may not qualify if…

• color blind
• abnormal laboratory test results
• major medical or neurological illness
• female who is pregnant, planning to be pregnant during the study period
• requiring treatment with a drug which might obscure the action of the study treatment

Where it is running

• Biofortis Clinical Research, Inc. — Addison, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.